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RESEARCH ARTICLE
APC/CCdh1 is required for the termination of chromosomal
passenger complex activity upon mitotic exit
Takaaki Tsunematsu1, Rieko Arakaki1, Hidehiko Kawai2, Jan Ruppert3, Koichi Tsuneyama4,
Naozumi Ishimaru1, William C. Earnshaw3, Michele Pagano5,6,7 and Yasusei Kudo1,8,*
ABSTRACT
During mitosis, the chromosomal passenger complex (CPC) ensures
the faithful transmission of the genome. The CPC is composed of the
enzymatic component Aurora B (AURKB) and the three regulatory
and targeting components borealin, INCENP, and survivin (also
known as BIRC5). Although the CPC is known to be involved in
diverse mitotic events, it is still unclear how CPC function terminates
after mitosis. Here we show that borealin is ubiquitylated by the
anaphase promoting complex/cyclosome (APC/C) and its cofactor
Cdh1 (also known as FZR1) and is subsequently degraded in G1
phase. Cdh1 binds to regions within the N terminus of borealin that act
as a non-canonical degron. Aurora B has also been shown previously
to be degraded by the APC/CCdh1 from late mitosis to G1. Indeed,
Cdh1 depletion sustains an Aurora B activity with stable levels of
borealin and Aurora B throughout the cell cycle, and causes reduced
efficiency of DNA replication after release from serum starvation.
Notably, inhibition of Aurora B kinase activity improves the efficiency
of DNA replication in Cdh1-depleted cells.We thus propose that APC/
CCdh1 terminates CPC activity upon mitotic exit and thereby
contributes to proper control of DNA replication.
KEYWORDS: Chromosome passenger complex, Borealin, Aurora B,
Ubiquitylation, APC/CCdh1
INTRODUCTION
The chromosomal passenger complex (CPC) plays an important
role during mitosis to ensure the faithful segregation of genetic
material into daughter cells (Earnshaw and Bernat, 1991). The CPC
consists of four proteins: Aurora B (AURKB), INCENP (inner
centromere protein), borealin (also known as CDCA8 and DASRA)
and survivin (also known as BIRC5). The CPC proteins were
originally defined by their pattern of localization to the
chromosomes and spindle during mitosis. Among CPC proteins,
Aurora B kinase is the enzymatic component, and the other three
proteins are regulatory and targeting components (Vagnarelli and
Earnshaw, 2004; Ruchaud et al., 2007).
Borealin was discovered in a proteomic screen for novel proteins
associated with mitotic chromosome scaffolds (Gassmann et al.,
2004) and, at the same time, in a screen for novel proteins capable of
binding to chromosomes in Xenopus extracts (Sampath et al., 2004).
The N terminus of human borealin participates in the three-helix
bundle that constitutes the CPC localization module (Jeyaprakash
et al., 2007). Immunoprecipitation experiments reveal that survivin
is associated with borealin in mitotic cells (Gassmann et al., 2004).
Borealin also binds INCENP and might be involved in targeting the
complex to centromeres. Borealin depletion by RNA interference
increases the percentage of prometaphase cells (Bekier et al., 2015)
and results in a dramatic increase in spindle–kinetochore
misattachments and failures in cytokinesis (Gassmann et al., 2004;
Sampath et al., 2004). These and a host of other observations indicate
that the CPC regulates mitosis. However, it is still unclear how CPC
activity is terminated after mitosis.
The APC/C (anaphase promoting complex/cyclosome) is a multi-
subunit E3 ubiquitin ligase mainly active during mitosis and G1. It
was originally identified as a ubiquitin ligase for cyclin B (King
et al., 1995; Yu et al., 1996). Activity and substrate binding by the
APC/C require the coactivator proteins, Cdc20 or Cdh1 (also known
as FZR1) (Visintin et al., 1997). Cdc20 associates with the APC/C
from prometaphase to anaphase and is responsible for the
ubiquitylation of important mitotic regulators such as cyclin B,
securin, and Kid (KIF22). Cdh1 maintains the activity of the APC/C
from late anaphase through G1, targeting multiple substrates for
degradation (Kramer et al., 1998). APC/CCdh1 activity decreases at
the onset of S phase, at which point inhibition by Emi1 (early
mitotic inhibitor 1, also known as FBXO5) and other mechanisms
prevent APC/CCdh1 activity until the next late mitosis (Di Fiore and
Pines, 2007;Machida and Dutta, 2007). Here, we show that borealin
is ubiquitylated and targeted for degradation by APC/CCdh1 during
the G1 phase of the cell cycle.
RESULTS
Borealin protein is degraded via APC/CCdh1 during G1
Borealin protein levels oscillate during the cell cycle; the protein
accumulates during G2 and M phases and disappears in G1
(Fig. 1A,B). We examined the involvement of the ubiquitin–
proteasome system (UPS) in the regulation of borealin protein
levels during the cell cycle. Treatment of HeLa cells with either of
two proteasome inhibitors (MG132 or lactacystin) resulted in
borealin protein accumulation at 7 h after releasing HeLa cells
from mitosis (Fig. 1C). This accumulation of borealin was not
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observed in asynchronous cells after treatment with MG132 or
lactacystin (Fig. 1C).
It is known that APC/C and multi-subunit cullin–RING ubiquitin
ligase complexes are most intimately dedicated to basic cell-cycle
control (Petroski and Deshaies, 2005). We first examined whether a
specific cullin–RING complex or APC/Cwas involved in regulating
borealin degradation. Borealin was found to co-immunoprecipitate
with Cdh1 and an APC/C core subunit, Cdc27, but not Cdc20
(Fig. 2A; Fig. S1A). None of the cullin family proteins tested bound
to borealin (Fig. 2A). Moreover, GST–borealin directly bound to
in vitro-translated Cdh1 protein (Fig. 2B). The fact that borealin
levels were found to be low in G1 and to rise during late S, G2 andM
is consistent with the idea that borealin is an APC/CCdh1 substrate
(Fig. 1B). Indeed, APC/CCdh1 substrates, including Aurora B and
cyclin B, were also downregulated during G1 (Fig. 1A). Moreover,
ectopic Cdh1 overexpression downregulated borealin levels
(Fig. 2C; Fig. S1B), and Cdh1 depletion stabilized borealin
protein during interphase (Fig. 2D). In vivo ubiquitylation of
borealin was inhibited by Cdh1 knockdown, but not by Cdc20
knockdown (Fig. 2E). These findings indicate that borealin protein
stability and levels are directly regulated by APC/CCdh1.
Two N-terminal regions in borealin are essential for Cdh1
binding and APC/CCdh1-mediated polyubiquitylation
Next, we investigated the mechanistic details of the APC/CCdh1-
mediated degradation of borealin. Cdh1 activates the APC/C by
contributing to substrate recognition (Hall et al., 2004; Zachariae,
2004). APC/C substrates contain one or more of several types of
short peptide motifs with highly degenerate sequences that are
required for their degradation, referred to as APC/C degrons.
Borealin has three putative D-box (RxxL, where x indicates any
amino acid) motifs, which could potentially be recognized by the
APC/CCdh1 (Fig. S2A). Wild-type borealin, individual D-box
mutants and a mutant with all D-box motifs disrupted were all
degraded following co-transfection of Cdh1 (Fig. S2B,C),
suggesting that none of the three putative D-box motifs is
responsible for the degradation of borealin protein.
To find the borealin degron, we generated several deletion
mutants (Fig. S3A) and evaluated the binding of these mutants to
Cdh1 (Fig. S3B). This analysis revealed that the residues 18–39 and
69–77 were required for Cdh1 binding (Fig. S3A,B) and
ubiquitylation (Fig. S3C). It has been shown that borealin
residues W70 and F74 dock into the hydrophobic pocket present
Fig. 1. Borealin is degraded at G1 phase
via the ubiquitin–proteasome pathway.
(A) HeLa cells were released from a
prometaphase arrest with nocodazole
(Noc) and collected at the indicated times
(left panel). In addition, HeLa cells were
synchronized at the G1-S border using a
double thymidine block (DTB). After
release, cells were collected at the
indicated time points (right panel). Cells
were then lysed for immunoblotting as
indicated. β-actin expression was used as
a loading control. As; asynchronous.
(B) The schematic graph shows protein
expression level of borealin and APC/C
activity during cell-cycle progression,
based on the results shown in A. (C) HeLa
cells were synchronized in M phase by
mitotic shake-off with nocodazole (M).
After 2 h release from mitotic arrest (G1),
cells were treated with or without 10 μM
MG132 or 10 μM lactacystin for 5 h.
Asynchronous cells (As) were also treated
with or without 10 μM MG132 or 10 μM
lactacystin for 5 h. Cells were then
collected and lysed for immunoblotting as
indicated. β-actin expression was used as
a loading control. Blots shown in A and C
are representative of two experiments.
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Fig. 2. See next page for legend.
3
RESEARCH ARTICLE Journal of Cell Science (2020) 133, jcs251314. doi:10.1242/jcs.251314
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
on the BIR (baculovirus inhibitor of apoptosis protein repeat)
domain of survivin and have only marginal contacts with INCENP
(Jeyaprakash et al., 2007). As previously reported (Jeyaprakash
et al., 2007), mutants in which these residues were replaced by
negatively charged amino acids (W70E/F74E) showed reduced
binding to survivin (Fig. S4A,B). TheW70E/F74E mutant was able
to bind Cdh1, but the W70E/F74E mutant with an additional
deletion of residues 18–39 (Δ18–39/W70E/F74E) could not bind to
Cdh1, even though the Δ18–39 mutant did bind to Cdh1 (Fig. S4C).
Thus, W70 and F74 contribute to Cdh1 binding. Because seven
amino acids within residues 18–39 were found to be highly
conserved among species, we generated 4A and 7A mutants (Fig.
S4A). Both 4A and 7A mutants bound to Cdh1 (Fig. S4C). We then
focused on all hydrophobic residues in this region (L21, F24, L25,
F28 and V32), which are also highly conserved among species and
are important for the interaction of borealin with survivin (Fig. 3A).
By mutating these conserved hydrophobic residues to charged
residues, the 5E mutant (L21E/F24E/L25E/F28E/V32E) and the
5E+W70E/F74E mutant (L21E/F24E/L25E/F28E/V32E with
W70E/F74E) were generated (Fig. 3A). Binding of the 5E+W70E/
F74Emutant to Cdh1was substantially reduced, compared to binding
of wild-type borealin, the W70E/F74E mutant and the 5E mutant
(Fig. 3B). The borealin 5E+W70E/F74E mutant remarkably
suppressed in vivo ubiquitylation (Fig. 3C). Computational
analysis of the region comprising amino acids 20–31 of borealin,
and its comparison with other APC/CCdh1 degrons, suggested that
borealin contains a non-canonical D box (Davey andMorgan, 2016)
(Fig. S5).
Next, we examined whether the 5E+W70E/F74E mutant was
degraded upon expression of ectopic Cdh1. Degradation of the
5E+W70E/F74E mutant was not promoted in Cdh1 co-transfection
experiments (Fig. 3D). Notably, the expression level of the
5E+W70E/F74E mutant was higher than that of wild-type borealin
despite transfecting the same amount of plasmid, suggesting that
suppression of degradation might cause protein accumulation of the
5E+W70E/F74E mutant. To evaluate the stability of the 5E+W70E/
F74E mutant, we examined its behavior during G1. Compared to
wild-type borealin, the mutant was much more stable during G1
phase (Fig. 3E). We concluded that the 5E+W70E/F74E mutant is
not marked for degradation via APC/CCdh1.
Survivin interferes with borealin ubiquitylation
Based on the results of our co-immunoprecipitation experiments,
two regions (amino acids 18–39 and 68–77) are important for Cdh1
binding. Interestingly, these regions are also essential for forming
the core of the CPC together with survivin and INCENP
(Jeyaprakash et al., 2007). In the globular part of the CPC core
structure, borealin residuesW70 and F74 dock into the hydrophobic
pocket present on the BIR domain of survivin and have only
marginal contacts with INCENP (Jeyaprakash et al., 2007). Indeed,
wild-type survivin bound to borealin and INCENP (Fig. 4A). As
previously shown (Jeyaprakash et al., 2007), the W70E/F74E
mutant showed reduced binding with Aurora B, survivin, and
INCENP, compared to the binding of wild-type borealin (Fig. S6A).
Because L21, F24, F28 and V32 are residues involved in
interactions with both INCENP and survivin (Fig. 3A), the 5E
and 5E+W70E/F74Emutants, as expected, showed reduced binding
with CPC components (Fig. S6A). As shown in Fig. 3C,
ubiquitylation of the borealin 5E+W70E/F74E and Δ18–77
mutants was remarkably suppressed, when compared to that of
the 5E and W70E/F74E mutants. These findings suggest that
borealin ubiquitylation might depend on its interaction with
survivin. Therefore, we examined the involvement of survivin in
the ubiquitylation of borealin. Survivin depletion did not affect
borealin ubiquitylation (Fig. S6B). Surprisingly, overexpressed
wild-type survivin suppressed the ubiquitylation of borealin
(Fig. 4B). Moreover, the splice variant ΔEx3 survivin, which does
not bind to borealin (Noton et al., 2006), did not suppress the
ubiquitylation of borealin (Fig. 4A,B), suggesting that Cdh1 might
mainly recognize borealin in the complex with survivin, rather than
free borealin. To prove this hypothesis, we examined whether the
ubiquitylation of the borealin W70E/F74E mutant, which has
reduced binding to survivin, was not suppressed by survivin
overexpression. However, ubiquitylation of both the borealin
W70E/F74E mutant and wild-type borealin was suppressed by
survivin overexpression (Fig. 4C).
Sustained CPC activity induces early DNA replication
Previous reports show that Aurora B is also degraded by the APC/
CCdh1 from late mitosis to G1 (Nguyen et al., 2005; Stewart and
Fang, 2005; Floyd et al., 2013). Indeed, Cdh1 depletion stabilized
Aurora B protein during interphase (Fig. 2D). Present and previous
findings indicate that APC/CCdh1 regulates the protein level of
borealin and Aurora B after mitosis. However, it is still unclear how
CPC function terminates after mitosis. To determine the
involvement of APC/CCdh1 in the termination of CPC function,
we used Fzr1 (which encodes Cdh1) knockout mouse embryonic
fibroblasts (MEFs). First, we examined whether borealin and
Aurora B were stabilized in interphase of Fzr1−/− MEFs. As
expected, levels of borealin and Aurora B oscillated in Fzr1+/+
MEFs but were more stable throughout the cell cycle in Fzr1−/−
MEFs (Fig. 5A). Because CPC functions are dependent on the
action of Aurora B kinase (Vagnarelli and Earnshaw, 2004;
Ruchaud et al., 2007), we examined Aurora B activity by
detecting its activating phosphorylation on T232 (p-T232). In
Fzr1+/+ MEFs, Aurora B was phosphorylated mostly around
mitosis. In contrast, in Fzr1−/− MEFs, Aurora B p-T232 was
detected in interphase (Fig. 5A). It is well known that the mitotic
phosphorylation of histone H3 at S10 (H3 p-S10) is governed by
Aurora B (Crosio et al., 2002). To asses CPC activity throughout the
Fig. 2. Borealin is degraded at G1 phase via APC/CCdh1-mediated
polyubiquitylation. (A) 293T cells were co-transfected with FLAG–Borealin
and empty vector (EV), HA–Cdh1, HA–Cdc20, Myc–CUL1, Myc–CUL2, Myc–
CUL3, Myc–CUL4, or Myc–CUL5. Then, cells were treated with 10 µMMG132
for 5 h. Cell extracts were immunoprecipitated (IP) with an affinity-purified
polyclonal antibody against HA or Myc, and analyzed by immunoblotting as
indicated. β-actin expression was used as a loading control. WCE: whole cell
extracts. Asterisk indicates non-specific bands. (B) GST-tagged wild-type
(WT) borealin bound to glutathione sepharose 4B resin was incubated with in
vitro translated (IVT) Cdh1 for 2 h at 4°C. After washing, these proteins were
eluted and analyzed by immunoblotting using anti-Cdh1 antibody. GST-
tagged borealin and GST were visualized by Coomassie Blue (CBB) staining.
IB, immunoblot. (C) HA-tagged Cdh1 (0, 0.5, 1.0, 1.5 and 2.0 μg) was co-
transfected with FLAG-tagged borealin (0.5 μg) in 293T cells. Cells were then
collected and lysed for immunoblotting as indicated. β-actin expression was
used as a loading control. (D) HeLa cells were transfected with control or Cdh1
siRNA and synchronized at prometaphase arrest using nocodazole (Noc).
After mitotic shake-off, cells were released and collected at the indicated times.
Cell extracts were immunoblotted for the indicated proteins. β-actin expression
was used as a loading control. (E) An in vivo ubiquitylation assay was
performed. FLAG-tagged borealin and HA-tagged ubiquitin were co-
transfected with either control, Cdc20 or Cdh1 siRNA in 293T cells. Cell
extracts were immunoprecipitated using an anti-FLAG antibody, and the
precipitates were blotted with anti-HA and anti-FLAG antibodies. Expression of
endogenous Cdc20 and Cdh1 was also examined. β-actin expression was
used as a loading control. Blots shown are representative of two experiments.
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cell cycle, we examined the levels of H3 p-S10 in G1, where H3
p-S10 is not observed. Large numbers of interphase nuclear foci of
H3 p-S10 and Aurora B were observed in Fzr1−/− MEFs,
compared to Fzr1+/+ MEFs (Fig. 5B). It has recently been
shown that nuclear foci of H3 p-S10 become visible in late S phase
and G2 (Ruppert et al., 2018). Indeed, nuclear foci ofH3 p-S10were
observed in the cells in G2 (cells with cyclin A expression) (Fig. 5C).
However, in Fzr1−/− MEFs, nuclear foci of H3 p-S10 were
also observed in the cells in G1 (cells without cyclin A
expression) (Fig. 5C). These nuclear foci of H3 p-S10 disappeared
Fig. 3. See next page for legend.
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upon treatment with the Aurora B kinase inhibitor, barasertib
(Fig. 5D), suggesting that APC/CCdh1 is required for termination of
CPC activity.
It has previously been shown that DNA replication is less
efficient in Cdh1 (Fzr1)-deficient MEFs (García-Higuera et al.,
2008). To determine the involvement of CPC activity in this
phenotype of Fzr1−/−MEFs, we examined whether this phenotype
could be rescued by barasertib treatment. DNA replication was
assessed by measuring EdU nucleotide incorporation after serum
starvation of Fzr1−/− and Fzr1+/+ MEFs. After re-adding serum,
Fzr1−/− MEFs entered S phase with kinetics different to those of
Fzr1+/+ MEFs. As previously reported (García-Higuera et al.,
2008), a greater number of Fzr1−/− MEFs than Fzr1+/+ MEFs had
entered S phase 21 h after serum stimulation (55% versus 40%)
(Fig. 5E). Moreover, the entry of Fzr1−/−MEFs into S phase peaked
at 21 h (55% of cells), compared with a peak at 27 h for Fzr1+/+
MEFs (74% of cells) (Fig. 5E). Thus, DNA replication was
apparently less efficient in Fzr1−/− MEFs, compared with Fzr1+/+
MEFs. Interestingly, barasertib treatment shifted the peak of S phase
in Fzr1−/−MEFs from 21 h to 24 h and improved the efficiency of
DNA replication from 55% to 68% (Fig. 5E). These findings
suggest that sustained CPC activity after mitosis might reduce the
efficiency of DNA replication.
DISCUSSION
Here, we have shown that borealin protein stability and levels are
directly regulated by APC/CCdh1. APC/C substrates contain one or
more of several types of short peptide motifs with highly degenerate
sequences, referred to as APC/C degrons. Borealin ubiquitylation
does not require a canonical D-box motif and/or a functional KEN
box, which are recognized by Cdh1. It appears that seven
hydrophobic residues (L21, F24, L25, F28, V32, W70, and F74)
are essential for Cdh1 binding. Computational analysis of the region
comprising amino acids 20–31 of borealin (20KLASFLKDFDRE31)
and its comparison with other APC/CCdh1 degrons suggested that
borealin contains a non-canonical D box (Fig. S5). Among APC/
CCdh1 degrons, a leucine residuewithin the canonical D-box sequence
(RxxL) may be common. Indeed, a single-alanine-substitution of
L295 within the O-box (291PASPLTEKNAK301) in Drosophila
ORC1 and L26 within the meiotic regulator Spo13 degron sequence
(26LxExxxN32) eliminate their polyubiquitylation (Araki et al., 2005;
Sullivan and Morgan, 2007). For borealin ubiquitylation, at least four
hydrophobic residues within the non-canonical D box
(20KLASFLKDFDRE31) are involved (Fig. S5).
Previous reports show that human cyclin A and yeast Clb5 each
contain a D box, an ABBA motif and a potential degenerate KEN
box, but also employ the Cdk-associated subunit Cks1 (CSK1B in
humans) to provide additional binding affinity for the APC/C (Lu
et al., 2014; Di Fiore et al., 2015). Therefore, borealin might require
residues W70 and F74, which are essential for the interaction with
survivin, for additional binding affinity to Cdh1. However, survivin
does not act as an adaptor of borealin ubiquitylation (Fig. S6B).
Surprisingly, wild-type survivin, but not the ΔEx3 mutant,
suppressed borealin ubiquitylation (Fig. 4B), suggesting that the
inhibitory effect on borealin ubiquitylation might be dependent on
the physical interaction between borealin and survivin. However,
survivin overexpression suppressed ubiquitylation of the borealin
W70E/F74E mutant, which shows less binding with survivin, as
well as wild-type borealin (Fig. 4C). Therefore, we suggest that
survivin may suppress the borealin ubiquitylation via interaction
with Cdh1, but not via direct interaction with borealin. To prove this
hypothesis, further experiments will be required.
The protein levels of Aurora B and borealin are regulated by
the UPS. During mitosis, Aurora B is ubiquitylated by two
midzone-associated E3 ubiquitin ligase complexes, CUL3–
KLHL9–KLHL13 (Sumara et al., 2007) and CUL3–KLHL21
(Maerki et al., 2009). Ubiquitylated Aurora B is subsequently
removed from anaphase chromosomes by the AAA+ ATPase
Cdc48 (cell division control protein 48; also known as p97 and
VCP) and its adaptor proteins Ufd1–Npl4 (Ramadan et al., 2007;
Dobrynin et al., 2011). This process is thought to contribute to
determining the levels and distribution of the CPC on
chromosomes before mitotic exit. From late mitosis to G1,
Aurora B is ubiquitylated by APC/CCdh1 via intact KEN-box and
A-box motifs (Nguyen et al., 2005; Stewart and Fang, 2005).
These findings indicate that distinct ubiquitin ligases regulate
different pools of Aurora B in space and time for orchestration of
proper control of mitosis. Surprisingly, formation of the CPC is
not always necessary for Aurora-B activity (Mackay et al.,
2010). Upon mitotic exit, APC/CCdh1-mediated degradation of
borealin and Aurora B might trigger the termination of CPC
function and Aurora B activity.
Faithful chromosome segregation during cell division is crucial for
growth, development and reproduction. Aneuploidy arising from
chromosomal instability (CIN) has been assumed to contribute to
carcinogenesis. Indeed, animal models have shown that failure to
control either chromosome segregation or cytokinesis can cause CIN
and cell transformation (Fujiwara et al., 2005; Iwanaga et al., 2007; Li
et al., 2009; Weaver et al., 2007). Aurora B is overexpressed in
various types of cancer, resulting in multi-nucleation and polyploidy
(Portella et al., 2011; Nguyen et al., 2009). Also, borealin is
overexpressed in colon and gastric cancers (Chang et al., 2006; Wang
et al., 2014). Therefore, degradation of borealin and Aurora B,
promoted by the APC/CCdh1 after mitosis, and subsequent timely
termination of CPC activity might be important for preventing
Fig. 3. N-terminal sequences of borealin are essential for Cdh1 binding
and APC/CCdh1-mediated polyubiquitylation. (A) Comparison of borealin
amino acid sequences of Homo sapiens, Mus musculus, Xenopus tropicalis
andDrosophila melanogaster from residues 18 to 30 and 68 to 77 of the human
sequence. Colored circles indicate residues involved in interactions with
INCENP (green circles) and survivin (blue circles), as shown in a previous
report (Jeyaprakash et al., 2007). (B) 293T cells were co-transfected with
empty vector (EV), FLAG-tagged wild-type (WT) borealin, FLAG-tagged
borealin 5E mutant (L21E/F24E/L25E/F28E/V32E), FLAG-tagged borealin
W70E/F74E mutant, FLAG-tagged borealin 5E+W70E/F74E mutant (L21E/
F24E/L25E/F28E/V32E/W70E/F74E), or FLAG-tagged borealin deletion
mutant (Δ18–77) and HA–Cdh1 and treated with 10 μM MG132 for 5 h. Cell
extracts were immunoprecipitated (IP) with an affinity-purified monoclonal
antibody against FLAG and analyzed by immunoblotting as indicated.
Ponceau S staining is shown as a loading control. WCE: whole cell extracts.
(C) An in vivo ubiquitylation assay was performed. EV, FLAG-tagged WT
borealin, or mutants were co-transfected with HA-tagged ubiquitin in 293T
cells. Cell extracts were immunoprecipitated using an anti-FLAG antibody and
analyzed by immunoblotting as indicated. Ponceau S staining is shown as a
loading control. (D) EV, FLAG-tagged WT borealin, or the 5E+W70E/F74E
borealin mutant were co-transfected with HA-tagged Cdh1 in 293T cells. Cell
extracts were immunoblotted with anti-HA and anti-FLAG antibodies. Vinculin
expression is shown as a loading control. Densitometric analysis of FLAG–
borealin and vinculin was performed. The graph shows the fold change of
FLAG–borealin:vincullin ratio in HA–Cdh1 transfected cells, compared with
empty vector transfected cells. (E) HeLa cells transfected with FLAG-tagged
WT borealin or FLAG-tagged borealin 5E+W70E/F74E mutant were
synchronized at prometaphase using nocodazole (M phase). Cells were
treated with 25 μg/ml cycloheximide (CHX) at 2 h after release from
nocodazole block (G1 phase) and collected at indicated time points. Cell
extracts were immunoblotted for the indicated proteins. Vinculin expression is
shown as a loading control. Blots in B–E are representative of two experiments.
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oncogenic events. Indeed, Cdh1-heterozygous animals have
increased susceptibility to spontaneous tumors (García-Higuera
et al., 2008). Moreover, Cdh1-deficient cells show early onset of
DNA replication and replication stress (García-Higuera et al., 2008;
Sigl et al., 2009). Interestingly, the abnormal DNA replication in
Fzr1−/− MEFs was rescued by Aurora B kinase inhibitor treatment
(Fig. 5B), suggesting that termination of CPC activity might
contribute to proper control of DNA replication.
In conclusion, we demonstrated that fluctuating borealin protein
levels across the cell cycle are regulated by APC/CCdh1. Cdh1
recognizes a unique non-canonical D-box sequence in borealin.
Because Aurora B protein levels are also regulated by APC/CCdh1
from late mitosis to G1, APC/CCdh1 might play an important role for
termination of CPC function and Aurora B activity upon mitotic exit
(Fig. 6). Whether abnormal accumulation of borealin and/or Aurora
B due to defects in APC/CCdh1 regulation contributes to cancer
etiology requires further studies.
MATERIALS AND METHODS
Cell culture and synchronization
293T and HeLa cells were obtained from the American type culture
collection (ATCC). U2OS cells conditionally expressing Myc–Cdh1 were
Fig. 4. Survivin interferes with borealin ubiquitylation. (A) HeLa cells transfected with empty vector (EV), Myc-tagged wild-type (WT) survivin or the survivin
ΔEx3 mutant were synchronized at prometaphase using nocodazole treatment. Cell extracts were immunoprecipitated (IP) using an anti-Myc antibody, and
blotted with anti-borealin, anti-INCENP and anti-Myc antibodies. β-actin expression was used as a loading control. WCE, whole cell extracts. (B) An in vivo
ubiquitylation assay was performed. FLAG-tagged WT borealin and HA-tagged ubiquitin were co-transfected with or without Myc-tagged WT survivin or
survivin ΔEx3 mutant in 293T cells. Cell extracts were immunoprecipitated using an anti-FLAG antibody, and blotted with anti-HA, anti-FLAG and anti-Myc
antibodies. β-actin expression was used as a loading control. The graph shows the densitometric analysis of borealin ubiquitylation. (C) An in vivo ubiquitylation
assay was performed. FLAG-tagged WT borealin or the W70E/F74E borealin mutant and HA-tagged ubiquitin were co-transfected with or without
Myc-tagged survivin in 293T cells. Cell extracts were immunoprecipitated using an anti-FLAG antibody, and blotted with anti-HA, anti-FLAG and anti-Myc
antibodies. Ponceau S staining is shown as a loading control. Blots in A–C are representative of two experiments.
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provided by Dr Jiri Lukas (Institute for Cancer Biology and Center
for Genotoxic Stress, Danish Cancer Society, Copenhagen, Denmark).
Wild-type and Fzr1−/− MEFs obtained from conditional knockout mice
with a targeted mutation in the Fzr1 locus were provided by Dr Marcos
Malumbres (National Cancer Research Centre, Madrid, Spain) (García-
Higuera et al., 2008). 293T, HeLa, U2OS cells and MEFs were maintained
in Dulbecco’s Modified Eagle’s Medium (D-MEM) (WAKO, Japan)
supplemented with heat-inactivated 10% fetal bovine serum (FBS)
(Invitrogen, San Diego, CA), at 37°C in 5% CO2.
For prometaphase arrest, HeLa cells were synchronized at prometaphase
using 50 ng/ml nocodazole (Sigma-Aldrich) treatment for 12 h followed by
mitotic shake-off. Subsequently, synchronized cells were released from the
mitotic arrest by washing out nocodazole. Cells were collected at the
indicated time points. HeLa cells were synchronized at the G1-S border
Fig. 5. See next page for legend.
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using a double thymidine block. In brief, cells were incubated for 20 h in
2 mM thymidine (Sigma-Aldrich), released for 8 h, and then incubated for
another 14 h in 2 mM thymidine. Cells were released from G1-S arrest by
washing out thymidine. At 6 h following release, cells were treated with
50 ng/ml nocodazole for 12 h followed by mitotic shake-off. Subsequently,
synchronized cells were released from the mitotic arrest by washing out
nocodazole. Cells were collected at the indicated time points.
MEFs were synchronized at the G1-S border using a double thymidine
block. In brief, cells were incubated for 20 h in 2 mM thymidine (Sigma-
Aldrich), released for 8 h, and then incubated for another 14 h in 2 mM
thymidine. Cells were release from G1-S arrest by washing out thymidine.
Cells were collected at the indicated time points.
Reagents and antibodies
MG132 (Z-Leu-Leu-Leu-CHO) and lactacystin were purchased from
Peptide Institute Inc. (Osaka, Japan). Cycloheximide (CHX) was
purchased from Sigma. Doxycycline was purchased from Clontech.
Aurora B-specific inhibitor, barasertib (AZD1152-HQPA) was obtained
from Selleckchem. For detection of borealin, an anti-borealin antiserum
raised in rabbit against human full-length borealin protein was previously
generated (Gassmann et al., 2004). Commercial antibodies used were:
mouse monoclonal anti-Aurora A, anti-Aurora B, and anti-p27Kip1
antibodies (#610938, #611082 and #610242, respectively; BD
Transduction Laboratories); rabbit polyclonal anti-INCENP (#2786; Cell
Signaling Technology); rabbit monoclonal anti-FoxM1 p-T600, anti-HA,
anti-Aurora A p-T288/Aurora B p-T232/Aurora C p-T198, and anti-vinculin
antibodies (#14655, #3724, #2914 and #13901, respectively; Cell Signaling
Technology); anti-Cdc23 and anti-INCENP antibodies (#ab72206 and
#ab12183; Abcam); rabbit monoclonal anti-Aurora B (#ab45145; Abcam);
mouse monoclonal anti-Cdh1/Fzr and anti-Cdc20 antibodies (#K0085-3
and #K0140-3, respectively; MBL); rabbit polyclonal anti-cyclin A
antibody (#sc-751; Santa-Cruz Biotechnology); mouse monoclonal anti-
cyclin B1 antibody (#sc-245; Santa-Cruz Biotechnology); anti-Cdc27 and
anti-β-actin antibodies (#C7104 and #A5441, respectively; Sigma-Aldrich);
mouse monoclonal anti-HA, anti-FLAG, anti-c-Myc, and anti-GFP
antibodies (#014-21881, #018-22381, #011-21874 and #012-22541,
respectively; Wako); rabbit polyclonal anti-survivin antibody (#NB500-
201; Novus Biologicals); rabbit polyclonal anti-Cul1 antibody (#71-8700;
Thermo Fisher Scientific); and rabbit polyclonal anti-H3 p-S10 antibody
(#06-570; Merck Millipore).
Plasmids
pEGFP-N1 plasmid encoding full-length human borealin was used for
constructing three different borealin D-box mutants; D1 (RRKL>ARKA),
D2 (RQNL>AQNA) and D3 (RKNL>AKNA) using the KOD plus
mutagenesis kit (Toyobo, Osaka, Japan). The pEGFP-N1-borealin
plasmid was digested by XhoI and KpnI followed by ligation with XhoI
and KpnI-digested pcDNA3.1 vector (Invitrogen) resulting in pcDNA3.1-
borealin plasmid. A FLAG-tag sequence was then inserted at the C
terminus of borealin using the KOD plus mutagenesis kit (Gassmann et al.,
2004). For generating various borealin mutants, pcDNA3.1-FLAG-
tagged-borealin was mutated using the KOD plus mutagenesis kit. For
production of borealin recombinant protein, borealin cDNA was inserted
to the EcoR1 site of the pGEX-4T-1 vector (GE Healthcare). pcDNA3-
HA-tagged human ubiquitin was kindly provided by Dr Anindya Dutta
(University of Virginia, Charlottesville, VA). pCMV-HA-tagged Cdh1
and Cdc20 were kindly provided by Dr Kristian Helin (Memorial Sloan
Kettering Cancer Institute, New York, NY). For in vitro translation, Cdh1
cDNAwas cloned into the pcDNA3.1 vector. pcDNA4-Myc tagged wild-
type and ΔEx3 survivin were provided by Dr Rachel Altura (The Ohio
State University, Columbus, OH).
DNA and siRNA transfection
DNA transfection or co-transfection into mammalian cells was conducted
using XtremeGENE HP transfection reagent (Roche) or PEI-Max
(Polysciences, Inc), according to the manufacturer’s instructions. 30 nM
of siRNA were transfected using Oligofectamine® RNAi MAX
(Invitrogen), according to the manufacturer’s instructions. Cdh1 and
Cdc20 siRNAs were obtained from Dharmacon as the following
sequences: Cdh1, 5′-UCUGGUGGACUGGUCGUCC-3′; Cdc20, 5′-GC-
CGGCAGGACUCCGGGCCGA-3′. Survivin siRNA was obtained from
Ambion as the following sequence: 5′-CAAAGGAAACCAACAAUAA-3′.
The negative control (siTrio negative control siRNA) was obtained from
Cosmo Bio Inc. (Tokyo, Japan).
Fig. 5. Cdh1 depletion induces early DNA replication. (A) Fzr1+/+ and
Fzr1−/− MEFs were synchronized at G1-S phase by double thymidine block
(DTB, see diagram). After release from G1-S arrest, cells were collected at the
indicated times. Cell extracts were immunoblotted for the indicated proteins.
M phase is evaluated by detection of FoxM1 p-T600. β-actin is shown as a
loading control. Asterisk shows the position of Aurora A p-T288. (B) Subcellular
colocalization of Aurora B and histone H3 p-S10 in Fzr1+/+ and Fzr1−/−MEFs.
Cells were fixed and stained using anti-H3 p-S10 (green) and anti-Aurora B
(red) antibodies. Nuclei of the cells were stained using DAPI (blue).
Arrowheads show H3 p-S10 in mitotic cells, and arrows show H3 p-S10 in
interphase cells. Scale bar: 20 µm. (C) Fzr1+/+ and Fzr1−/− MEFs were fixed
and stained using anti-H3 p-S10 (green) and anti-cyclin A (red) antibodies.
Nuclei of the cells were stained with DAPI (blue). Cyclin A expression was used
as a marker of G2 cells. Scale bar: 10 µm. (D) Fzr1−/−MEFs were treated with
the Aurora B specific inhibitor barasertib (10 nM) for 24 h. Cells were fixed and
stained using an anti-H3 p-S10 antibody (green). Nuclei of the cells were
stained using DAPI (blue). Scale bar: 10 µm. (E) Fzr1+/+ and Fzr1−/− MEFs
were serum starved for 72 h, forced to enter the cell cycle after stimulation with
15% FBS and pulsed with EdU. The percentage of EdU-positive cells was
scored at different time points. Three independent experiments were used to
calculate the mean±s.d. Blots and images in A–D are representative of at least
two experiments.
Fig. 6. Schematic model for CPC regulation fromM phase to G1 phase. In M phase, APC/CCdh1 is inactive. Because Aurora B and borealin are stable, CPC is
active. In G1 phase, borealin and Aurora B are ubiquitylated by APC/CCdh1, and CPC activity is terminated. The termination of CPC function via degradation of
borealin and Aurora B by APC/CCdh1 might be required for proper cell cycle control.
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Immunoprecipitation and immunoblot analysis
Cells were lysed using CPC lysis buffer (50 mM Tris-HCl pH 7.6, 400 mM
NaCl, 0.5% Nonidet P-40, 10 mM NaF, 0.1% sodium deoxycholate,
1.5 mM MgCl2, 100 nM okadic acid and 40 mM β-glycerophosphate) with
protease inhibitors and incubated on ice for 30 min adding Turbo nuclease
(Accelagen). After incubation, cells were centrifuged for 20 min at
13,200 rpm (17,000 g) and the supernatant was used as cell lysate.
For immunoprecipitation, cell lysate was diluted in NP-40 lysis buffer
(10 mM Tris-HCl pH 7.6, 150 mM NaCl, 0.5 mM EDTA, 10 mM NaF and
0.1% Nonidet P-40) with protease inhibitors and immunoprecipitated using
the specific antibody against the target protein. The immunoprecipitates
were subjected to immunoblot analysis. For immunoblotting, 30 µg of
protein was subjected to 10–20% gradient polyacrylamide gel (ATTO)
electrophoresis followed by electroblotting onto a nitrocellulose membrane
(GE Healthcare). To detect the immunocomplex, an Immobilon HRP
substrate (Merck Millipore) or ImmunoStar LD (Wako) was used. Primary
antibodies for immunoblot analysis were used at dilutions of 1:500 for Cdh1
and Cdc20, 1:1000 for borealin, INCENP, p27, Cyclin B, FoxM1 p-T600,
and Aurora-B p-T232, 1:2000 for Aurora-B, survivin, vinculin, FLAG, HA,
and Myc, and 1:10,000 for β-actin. Primary antibodies were used for
immunoprecipitation analysis at dilutions of 1:250 for HA and FLAG, and
1:500 for Myc.
GST pulldown assay
To prepare in vitro translated (IVT) Cdh1 recombinant protein, the TNT
Coupled Wheat Germ Extract System (Promega) was used with pcDNA3.1-
Cdh1 vector, following the manufacturer’s protocol. For GST-tagged
recombinant protein production, pGEX-4T-1-borealin vector was
transformed to BL21(DE3) (Nippon gene) and GST-tagged borealin was
expressed for 15 h at 18°C with 0.2 mM isopropyl-1-thio-D-
galactopyranoside (IPTG). Cells were lysed using NETN buffer (100 mM
NaCl, 1 mM EDTA, 50 mM Tris-HCl pH 7.5, 1 mM PMSF, 5 mM
benzamidine and 0.5% NP-40) and sonicated. After centrifugation, cleared
lysate was collected and incubated in GST SpinTrap columns (GE
healthcare) for 1 h at 4°C. Then, each column was washed three times
with binding buffer (10 mM Tris-HCl pH 7.6, 150 mM NaCl, 0.5 mM
EDTA, 10 mM NaF, 0.1% Nonidet P-40, 20 mM β-glycerophosphate and
20 nM okadic acid) and incubated with 15 μl IVT Cdh1 and binding buffer
for 2 h at 4°C. After incubation, each column was washed five times with
binding buffer and proteins were eluted using GST elution buffer (GE
healthcare). The eluted proteins were analyzed using SDS–PAGE.
In vivo ubiquitylation assay
293T cells transfected with FLAG–borealin and HA–ubiquitin were treated
with 40 μMMG132 for 1 h at 36 h following transfection. Cells were lysed
with denaturing ubiquitination buffer (50 mM Tris-HCl pH 7.6, 5 mMDTT
and 1% SDS) and immediately boiled for 10 min at 95°C. After denaturing,
cell lysates were sonicated and centrifuged for 20 min at 13,200 rpm
(17,000 g). The supernatant was diluted using immunoprecipitation buffer
(50 mM Tris-HCl pH 7.6, 5% glycerol, 150 mM KCl and 0.4% Nonidet P-
40) with protease inhibitors, then immunoprecipitated using anti-FLAG
monoclonal antibody (Wako). Immunoprecipitated ubiquitylated proteins
were fractionated using SDS–PAGE, transferred, and immunoblotted using
anti-HA antibody.
Immunofluorescence
Cells were grown on glass coverslips, fixed in methanol:acetone (1:1) for
10 min. After blocking using 3% BSA, the coverslips were incubated with
primary antibodies. Primary antibody dilutions used were 1:100 for Aurora-
B, and 1:200 for H3 p-S10 and Cyclin A. Alexa Fluor 488-conjugated anti-
rabbit IgG and Alexa Fluor 555-conjugated anti-mouse IgG, or Alexa Fluor
488-conjugated anti-mouse IgG and Alexa Fluor 555-conjugated anti-rabbit
IgG were used as secondary antibodies (Invitrogen). DNA was visualized
using 4′,6-diamidino-2-phenylindole (DAPI) staining. Immunostaining of
the cell preparations was recorded using an epifluorescence Zeiss Axioplan
2 microscope (Zeiss, Inc., Thornwood, NY), with Plan-Neofluar 40×/0.75
Ph2 and 63x Plan-Apochromat 63×/1.4 NA oil-immersion objective lenses,
attached to a charge-coupled-device camera.
EdU staining
For EdU incorporation experiments, MEF cells were synchronized in G0
phase by serum starvation. After 72 h, cells were treated with 15% FBS and
pulsed with EdU. EdU staining was performed using a Click-iT Plus EdU
Flow Cytometry Assay Kit (Life Technologies) according to the
manufacturer’s protocol. Briefly, cells were treated with 10 µM EdU for
30 min before each indicated time point. MEFs were then fixed in 4%
paraformaldehyde for 15 min, stained with Alexa Fluor 488–picolyl azide
and analyzed by flow cytometry. Three independent experiments were used
to calculate mean±s.d.
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